4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[2-(3,3,5,5-tetramethylcyclohexyl)ethyl]-1H-pyrazole
Structure Info
- Chemspace ID
- CSSB06801165681 (In-Stock Building Blocks)
- IUPAC Name
- 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[2-(3,3,5,5-tetramethylcyclohexyl)ethyl]-1H-pyrazole
- Mol formula
- C21H37BN2O2
- Mol weight
- 360 Da
- Catalog Number(s)
- BBLS06801165681, BBV-837095561, EN300-54492492, bbls06801165681
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 5.92
- Heavy atoms count
- 26
- Rotatable bond count
- 4
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.857
- Polar surface area (Å)
- 36
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[2-(3,3,5,5-tetramethylcyclohexyl)ethyl]-1H-pyrazole (C21H37BN2O2) - CSSB06801165681](/st/structure/200/c151d122e9e526549e13c96c529c2d9f/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2cnn%2528CCC3CC%2528C%2529%2528C%2529CC%2528C%2529%2528C%2529C3%2529c2.png "C21H37BN2O2")
- Zoom the structure
- CSSB06801165681
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 815.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 855.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 894.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 932.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 971.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,903.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 2,816.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 4,176.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 1-(2-{spiro[2.3]hexan-5-yl}ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole - CSSB14882089942](/st/structure/200/450a6b09e1676f50fc5e8be9cb5e977f/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2cnn%2528CCC3CC4%2528CC4%2529C3%2529c2.png)
![Chemical structure of 1-[2-(3,3-dimethylcyclopentyl)ethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole - CSSB03452709468](/st/structure/200/81504a4686a096ec66453d414b4426ff/CC1%2528C%2529CCC%2528CCN2C%253DC%2528C%253DN2%2529B2OC%2528C%2529%2528C%2529C%2528C%2529%2528C%2529O2%2529C1.png)
![Chemical structure of 1-(2-{spiro[3.3]heptan-2-yl}ethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole - CSSB21229158847](/st/structure/200/7948323374f698c4b167d74cd6cdd837/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CCC2CC3%2528CCC3%2529C2%2529N%253DC1.png)
![Chemical structure of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[(3,3,5,5-tetramethylcyclohexyl)methyl]-1H-pyrazole - CSSB02231461270](/st/structure/200/944574f5ec92e5362f8e43964bcf96b3/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCN%2528CC2CC%2528C%2529%2528C%2529CC%2528C%2529%2528C%2529C2%2529N%253DC1.png)
![Chemical structure of 1-[2-(3,3-difluorocyclobutyl)ethyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole - CSSB03555815285](/st/structure/200/1b0a369869fa29dbbda37919a59d8fd1/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2cnn%2528CCC3CC%2528F%2529%2528F%2529C3%2529c2.png)
![Chemical structure of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-[2-(2,2,6,6-tetramethyloxan-4-yl)ethyl]-1H-pyrazole - CSSB06802822382](/st/structure/200/15b5433a7aeeee72c78816b59f5e4a87/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529c2cnn%2528CCC3CC%2528C%2529%2528C%2529OC%2528C%2529%2528C%2529C3%2529c2.png)
